A major news story from Sanofi this month is that "The European Medicines Agency has approved Dupixent (dupilumab) to treat ...

PARIS, Oct 16 (Reuters) - French unions have called on workers at Sanofi (SASY.PA), opens new tab to strike from Thursday to protest a planned sale of the pharmaceutical group's consumer health ...

Bonne nouvelle pour le quartier d'affaires. A l'été 2027, au moins 2.700 des 3.700 salariés du site de Gentilly devraient ...

PARIS, Oct 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U ...

PARIS (Agefi-Dow Jones)--Le laboratoire pharmaceutique Sanofi a annoncé jeudi que le Comité des médicaments à usage humain ...

Sanofi has launched a new initiative in its drive to integrate digital technologies throughout its business, setting up an accelerator based in Paris that will serve as the lynchpin of the effort.

(AOF) - Amundi Amundi a annoncé l'acquisition d'aixigo, société technologique ayant développé une offre de services modulaire pour les ...

Sanofi a installé à Paris un « accélérateur digital » afin d'intégrer l’intelligence artificielle aux logiciels de recherche.

The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.35 per share.

Brad Lightcap, COO, OpenAI "We believe AI can accelerate drug development, bringing new treatments to patients more quickly. This first product from our collaboration with Sanofi and Formation Bio is ...

Paris: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic ...

Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...